Aprotinin Kidney Failure
AttorneyOne.com is a free nationwide legal referral service. We are not a law firm. We help consumers find the best representation for their legal needs.
If you or a loved one are in need of legal assistance concerning Aprotinin Kidney Failure you should get a lawyer on your side immediately. You will pay no attorney fees unless you win your case.
Email up to 10 Aprotinin Kidney Failure law firms in one click; by filling out the simple Free Case Evaluation form.
For additional info on Aprotinin Kidney Failure use the related topic links on the far right.
Aprotinin Kidney Failure In The News
Study likely spells end for anti-bleeding drugAn anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs. Bayer AG, the maker of the drug Trasylol, said it is still deciding what to do and is awaiting details from the Canadian study. Bayer faces dozens of lawsuits claiming Trasylol led to ..
Study likely spells end for anti-bleeding drugAn anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery
Study likely spells end for anti-bleeding drugAn anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs. Bayer AG, the maker of the drug Trasylol, said it is still deciding what to do and is awaiting details from the Canadian study. Bayer faces dozens of lawsuits claiming Trasylol ...
Study likely spells end for anti-bleeding drugAn anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the...
Bayer pulls Trasylol supplies after studyBayer AG is removing remaining supplies of its heart-surgery drug Trasylol from the U.S. market after a long-awaited study found it raised the risk of death compared to two alternatives, U.S. regulators said on Wednesday.
Bayer pulls anti-bleeding drugAn anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were more likely to die.
Study likely spells end for anti-bleeding drugThu, May 15, 2008 (7:22 a.m.) An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs.
Blood-clotting drug linked to death riskPatients who received a drug commonly used to control bleeding during heart surgery were at a higher risk of dying, new research by the Ottawa Health Research Institute reveals.
Bayer's Trasylol seen unlikely to be sold againTrasylol, which Bayer withdrew from the market when evidence showed it raised the risk of death, is not likely to be sold again to reduce bleeding in high-risk heart surgery, according to a long-awaited study and commentary published on Wednesday.
Study likely spells end for anti-bleeding drugAn anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs.
